[go: up one dir, main page]

WO2006008650A3 - Dna methylation in the assessment of leukemia - Google Patents

Dna methylation in the assessment of leukemia Download PDF

Info

Publication number
WO2006008650A3
WO2006008650A3 PCT/IB2005/002369 IB2005002369W WO2006008650A3 WO 2006008650 A3 WO2006008650 A3 WO 2006008650A3 IB 2005002369 W IB2005002369 W IB 2005002369W WO 2006008650 A3 WO2006008650 A3 WO 2006008650A3
Authority
WO
WIPO (PCT)
Prior art keywords
leukemia
assessment
dna methylation
methods
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2005/002369
Other languages
French (fr)
Other versions
WO2006008650A2 (en
Inventor
Martin Matthew Corcoran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karolinska Innovations AB
Original Assignee
Karolinska Innovations AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations AB filed Critical Karolinska Innovations AB
Publication of WO2006008650A2 publication Critical patent/WO2006008650A2/en
Publication of WO2006008650A3 publication Critical patent/WO2006008650A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

This invention relates to methods for assessing leukemia in a patient, in particular to methods in which leukemia is assessed by analysis of the methylation of the ZAP70 gene in a in a sample obtained from the patient. Methods and means of assessing leukaemia and providing a positive or negative prognosis are provided.
PCT/IB2005/002369 2004-07-16 2005-07-15 Dna methylation in the assessment of leukemia Ceased WO2006008650A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58864204P 2004-07-16 2004-07-16
US60/588,642 2004-07-16

Publications (2)

Publication Number Publication Date
WO2006008650A2 WO2006008650A2 (en) 2006-01-26
WO2006008650A3 true WO2006008650A3 (en) 2006-12-07

Family

ID=35785597

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/002369 Ceased WO2006008650A2 (en) 2004-07-16 2005-07-15 Dna methylation in the assessment of leukemia

Country Status (1)

Country Link
WO (1) WO2006008650A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1862555A1 (en) * 2006-05-29 2007-12-05 Klinikum der Universität Regensburg Means and methods for diagnosing cancer or a corresponding predisposition
WO2014056986A1 (en) 2012-10-11 2014-04-17 Universitat De Barcelona Method to predict the clinical evolution of a patient suffering of chronic lymphocytic leukemia (cll)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203416A1 (en) * 2002-04-25 2003-10-30 The Govt. Of The Usa As Represented By Secretary Of The Dept. Of Health And Human Services ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203416A1 (en) * 2002-04-25 2003-10-30 The Govt. Of The Usa As Represented By Secretary Of The Dept. Of Health And Human Services ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FROMMER M ET AL: "A GENOMIC SEQUENCING PROTOCOL THAT YIELDS A POSITIVE DISPLAY OF 5-METHYLCYTOSINE RESIDUES IN INDIVIDUAL DNA STRANDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 89, March 1992 (1992-03-01), pages 1827 - 1831, XP002941272, ISSN: 0027-8424 *
OSCIER D G ET AL.: "Zap70 methylation correlates with Zap70 expression", BLOOD, vol. 104, no. 11/1, 16 November 2004 (2004-11-16), pages 276A, XP008069019 *

Also Published As

Publication number Publication date
WO2006008650A2 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
WO2007095644A3 (en) Reagents and methods for cancer prognosis and pathological staging
WO2009032974A3 (en) Nucleic acid-based methods for the detection of ovarian cancer
WO2008069906A3 (en) Digital expression of gene analysis
WO2007120859A3 (en) Methods for increasing accuracy of nucleic acid sequencing
WO2010019414A3 (en) Detecting nucleic acid
EP4105644A3 (en) Systems and devices for sequence by synthesis analysis
WO2007039319A8 (en) Dna microarray for rapid identification of candida albicans in blood cultures
EP2574679A3 (en) Methods for in vitro hepatocellular carninoma prognosis
WO2009134944A3 (en) Methods of determining the health status of an individual
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2008005321A3 (en) Systems and methods for real-time pcr
WO2007070376A8 (en) Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
WO2010129937A3 (en) Methods for detecting genetic variations in dna samples
WO2008070862A3 (en) Non-invasive prenatal genetic screen
WO2005076887A3 (en) Methods and systems for sampling, screening, and diagnosis
WO2006108674A3 (en) Elite event a2704-12 and methods and kits for identifying such event in biological samples
WO2007146819A3 (en) Methods for identifying and using snp panels
EP2177614A3 (en) Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
WO2009124255A8 (en) Methods for transcript analysis
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2008073378A3 (en) High throughput dna sequencing method and apparatus
WO2005116257A3 (en) Unique short tandem repeats and methods of their use
WO2008063655A3 (en) Dna methylation markers and methods of use
WO2007001081A3 (en) Method , array , apparatus and test system to discriminate individuals
WO2009058331A3 (en) Biomarkers for the detection of early stage ovarian cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05766737

Country of ref document: EP

Kind code of ref document: A2